Campus News

April 25, 2014
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
October 27, 2011
UCSF will celebrate “Clinical Research Education Day’’ as the host of Aware for All – San Francisco, a free health education program that is open to the public and designed to help people make informed decisions about participating in clinical research.
October 26, 2011
An 11-month-old partnership between UCSF and Pfizer, Inc., aimed at rapidly moving new therapies into human clinical trials, has selected its first projects for funding and joint development.
November 29, 2010
A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor’s metabolism.
November 16, 2010
UCSF and Pfizer, Inc. have formed a new partnership to accelerate the translation of biomedical research into effective new medications and therapies for patients.
November 15, 2010
UCSF researchers have for the first time shown that an external optical pacemaker can be used in a vertebrate to control its heart rate.
November 04, 2010
UCSF global health experts have outlined a new strategy and action plan to help countries eliminate malaria and bring the world closer to global eradication of the deadly disease.
November 03, 2010
UCSF Nobel laureate Elizabeth Blackburn, PhD, and researcher Elissa Epel, PhD, are co-authors with UC Davis scientists of a paper showing that the positive psychological changes that occur during meditation training are associated with greater activity of the enzyme telomerase.
October 22, 2010
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
September 24, 2010
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.

Pages